Developed by Halocinch Medical, the second-generation HaloChord® Transcatheter Mitral Valve Chordal Repair represents a ground breaking medical innovation. This system is the first in the world capable of implanting two sets of artificial chordae tendineae in a single procedure. It utilizes an adjustable fixture to securely anchor the artificial chordae tendineae at the apex of the heart, providing a reliable and innovative solution for mitral valve chordae tendineae repair.
Minimally Invasive: Compared to traditional surgical methods, the HaloChord® system offers significantly reduced surgical trauma and shorter recovery times, alleviating patient discomfort and suffering.
Preserves Anatomy: Unlike mitral valve clamp procedures, it preserves the valve’s natural anatomical structure, maintaining the potential for future treatments.
Current Status: The system is currently undergoing multi-center clinical trials nationwide.
The HaloChord® System is poised to pioneer new approaches in mitral valve chordae tendineae repair, offering a promising new option for patients and advancing the field of cardiac surgery.